A clinical trial involving leptin was updated on September 18, 2026. The study, titled "Biobehavioral Reward Responses Associated With Consumption of Nutritionally Diverse Ultra-Processed Foods," is registered as NCT05437809. Its current status is listed as active, not recruiting. The trial phase is designated as not applicable.
This update reflects a change in recruitment status only. No results have been posted for this trial as of this update. The trial record does not provide outcome data, efficacy claims, or safety findings at this stage.
Leptin remains an approved compound, and this trial represents ongoing research activity rather than a new regulatory action. Readers should note that active, not recruiting status means enrollment has closed but the study has not yet concluded or reported findings.
Further details about the trial design, objectives, and eventual results can be found through the official clinical trial registry listing. As with any active trial, conclusions should not be drawn until results are formally released and published.
For more background on leptin, including its approved uses and general profile, readers can consult the compound overview.